Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital
October 29, 2015 10:40 AM EDTThe potential Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) deal would bring attractive strategic and financial aspects and focus will shift to the likelihood of actually getting done if the price is right and management structure can be agreed... More
Pfizer (PFE) Confirms Discussions with Allergan (AGN)
October 29, 2015 10:10 AM EDTPfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More
Pfizer (PFE) Offering $375 - $400/Share for Allergan (AGN) Might Seal Deal - Leerink
October 29, 2015 10:07 AM EDTLeerink is out with commentary on Allergan (NYSE: AGN) following news that it and Pfizer (NYSE: PFE) are in talks over a potential deal.
Analyst Jason Gerberry is updating his Pfizer-Allergan model, which assumes at $375 per Allergan share takeover price. The analyst commented:
Following recent speculation that PFE (MP) and AGN are in discussions around a potential merger, we weigh in on (1) price; (2) people factor; (3) AGN M&A... More
Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get Done
October 29, 2015 9:50 AM EDTFollowing an eye-opening report late Wednesday from the WSJ, Allergan (NYSE: AGN) confirmed this morning that it has been... More
